Visual Abstract: Efficacy, Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MAY 9, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.0901?guestAccessKey=fe55a8ce-c321-43c1-8ef9-13a433ba3ac5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050922

 

Visual Abstract

Authors: Yuishin Izumi, M.D., Ph.D., of the Tokushima University Graduate School of Biomedical Sciences in Tokushima, Japan, is the corresponding author.

(doi:10.1001/jamaneurol.2022.0901)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.